Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.66M | 30.60M | 61.00K | 513.00K | 1.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.66M | 30.60M | 61.00K | 513.00K | 1.14M |
| Cost of Revenue | 907.00K | 48.61M | 47.64M | 2.13M | 2.91M |
| Gross Profit | 3.75M | -18.01M | -47.58M | -1.61M | -1.77M |
| SG&A Expenses | 13.38M | 16.35M | 18.09M | 18.21M | 19.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.97M | 64.97M | 65.73M | 72.42M | 68.13M |
| Operating Income | -35.31M | -34.36M | -65.67M | -71.90M | -66.99M |
| Income Before Tax | -76.09M | -45.40M | -62.14M | -67.61M | -61.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -76.09M | -45.40M | -62.14M | -67.61M | -61.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.09M | -45.40M | -62.14M | -67.61M | -61.95M |
| EBIT | -35.31M | -34.36M | -65.67M | -71.90M | -66.99M |
| EBITDA | -33.39M | -32.98M | -64.07M | -70.48M | -65.58M |
| EPS Basic | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| Normalized Basic EPS | -0.27 | -0.25 | -0.47 | -0.51 | -0.47 |
| EPS Diluted | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 |
| Normalized Diluted EPS | -0.27 | -0.25 | -0.47 | -0.51 | -0.47 |
| Average Basic Shares Outstanding | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M |
| Average Diluted Shares Outstanding | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |